Ketorolac for Pain Control With Intrauterine Device Placement

Obstetrics and Gynecology

Volumn 126, Issue 1, 2015, Pages 29-36

  Ngo, Lynn L ^b   Ward, Kristy K ^a   Mody, Sheila K ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Women's Health Sciences Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETOROLAC; PLACEBO; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AFRICAN AMERICAN; ANALGESIA; APPLICATION SITE PAIN; ARTICLE; ASIAN; BODY MASS; BREAST FEEDING; CAUCASIAN; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EDUCATIONAL STATUS; FEMALE; HISPANIC; HUMAN; INJECTION SITE PAIN; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; NULLIPARA; OUTCOME ASSESSMENT; PACIFIC ISLANDER; PARITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFUSAL TO PARTICIPATE; UTERINE CERVIX BIOPSY; UTERINE TENACULUM; VISUAL ANALOG SCALE; ADOLESCENT; DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PATIENT SATISFACTION; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; INTRAUTERINE DEVICES; KETOROLAC; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PATIENT SATISFACTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84932165698     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000912     Document Type: Article

References (24)

1. Trussell J. Contraceptive failure in the United States. Contraception 2011;83:397-404.
2. Branum A, Jones J. Trends in long-acting reversible contraception use among U. S. women aged 15-44. NCHS Data Brief 2015:1-8.
3. Bracken J, Graham CA. Young women's attitudes towards, and experiences of, long-acting reversible contraceptives. Eur J Contracept Reprod Health Care 2014;19:276-84.
4. Michie L, Cameron ST, Glasier A, Wellings K, Loudon J. Myths and misconceptions about intrauterine contraception among women seeking termination of pregnancy. J Fam Plann Reprod Health Care 2014;40:36-40.
5. Weston MR, Martins SL, Neustadt AB, Gilliam ML. Factors influencing uptake of intrauterine devices among postpartum adolescents: a qualitative study. Am J Obstet Gynecol 2012; 206:40. e1-7.
6. Asker C, Stokes-Lampard H, Beavan J, Wilson S. What is it about intrauterine devices that women find unacceptable? Factors that make women non-users: a qualitative study. J Fam Plann Reprod Health Care 2006;32:89-94.
7. Long-acting reversible contraception (LARC): IUD and implant. ACOG FAQ No. 184. American Congress of Obstetricians and Gynecologists. 2014. Available at: http://www.acog. org/Patients/FAQs/Long-Acting-Reversible-Contraception-LARC-IUD-and-Implant.
8. Nelson AL, Fong JK. Intrauterine infusion of lidocaine does not reduce pain scores during IUD insertion. Contraception 2013; 88:37-40.
9. Allen RH, Bartz D, Grimes DA, Hubacher D, O'Brien P. Interventions for pain with intrauterine device insertion. The Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD007373. DOI: 10. 1002/14651858. CD007373. pub2.
10. Edelman AB, Schaefer E, Olson A, Van Houten L, Bednarek P, Jensen JT, et al. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception 2011;84:234-9.
11. Maguire K, Davis A, Rosario Tejeda L, Westhoff C. Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception 2012;86:214-9.
12. Mody SK, Kiley J, Rademaker A, Gawron L, Stika C, Hammond C. Pain control for intrauterine device insertion: a randomized trial of 1% lidocaine paracervical block. Contraception 2012;86:704-9.
13. Karabayirli S, Ayrim AA, Muslu B. Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. J Minim Invasive Gynecol 2012; 19:581-4.
14. Massey SE, Varady JC, Henzl MR. Pain relief with naproxen following insertion of an intrauterine device. J Reprod Med 1974;13:226-31.
15. Fiedler MA. Clinical implications of ketorolac for postoperative analgesia. J Perianesth Nurs 1997;12:426-33.
16. Ketorolac. DrugPoints Summary. Micromedex 2. 0. Truven Health Analytics, Inc: Greenwood Village, CO. Available at: http://www.micromedexsolutions. com. Retrieved January 8, 2012.
17. Braaten KP, Hurwitz S, Fortin J, Goldberg AB. Intramuscular ketorolac versus oral ibuprofen for pain relief in first-trimester surgical abortion: a randomized clinical trial. Contraception 2014;89:116-21.
18. Roche NE, Li D, James D, Fechner A, Tilak V. The effect of perioperative ketorolac on pain control in pregnancy termination. Contraception 2012;85:299-303.
19. Chor J, Bregand-White J, Golobof A, Harwood B, Cowett A. Ibuprofen prophylaxis for levonorgestrel-releasing intrauterine system insertion: a randomized controlled trial. Contraception 2012;85:558-62.
20. Rowbotham MC. What is a 'clinically meaningful' reduction in pain? Pain 2001;94:131-2.
21. Todd KH, Funk KG, Funk JP, Bonacci R. Clinical significance of reported changes in pain severity. Ann Emerg Med 1996;27: 485-9.
22. Hubacher D, Reyes V, Lillo S, Zepeda A, Chen PL, Croxatto H. Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol 2006;195:1272-7.
23. Jensen HH, Blaabjerg J, Lyndrup J. Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion [in Danish]. Ugeskr Laeger 1998;160:6958-61.
24. Bednarek PH, Creinin MD, Reeves MF, Cwiak C, Espey E, Jensen JT, et al. Prophylactic ibuprofen does not improve pain with IUD insertion: a randomized trial. Contraception 2015;91:193-7.